✅ DDx: Abdominal Pain / Diarrhea / GI Bleed Flashcards
Blunt abdominal trauma (BAT)
After primary survey, patients with BAT should be assessed for the presence of intra-abdominal organ injury with a bedside Focused Assessment with Sonography for Trauma (FAST), which evaluates both the abdomen and pericardium. Hemodynamically unstable patients with positive FAST (eg, intraperitoneal fluid) should be taken for exploratory laparotomy.
Cx:
Hepatic laceration (HL), one of the most common solid organ injuries, along with splenic lacerations, due to BAT. Other manifestations of HL include right upper quadrant pain and right shoulder pain due to irritation of the phrenic nerve from hemorrhage. Factors increasing the likelihood of intra-abdominal injury include the “seat belt sign” (ecchymosis over the abdomen in the pattern of a seat belt), rebound tenderness, abdominal distension/guarding, and concomitant femur fracture.
Urethral injury (eg, blood at the urethral meatus, high-riding prostate).
Anterior urethral injury: penile trauma (eg, laceration, contusion) is often visible.
Bulbomembranous junction (junction of the anterior and posterior urethra) is the most common site of urethral injury.
Posterior urethral injury (eg, membranous urethral injury) and bulbomembranous transection, digital rectal examination may reveal a high-riding prostate.
Extraperitoneal bladder injury (EPBI) may consist of either contusion or rupture of the neck, anterior wall, or anterolateral wall of the bladder. In the case of rupture, extravasation of urine into adjacent tissues causes localized pain in the lower abdomen and pelvis. Pelvic fracture is almost always present in EPBI, and sometimes a bony fragment can directly puncture and rupture the bladder. Gross hematuria is also usually present, and urinary retention (evidenced by suprapubic fullness in this patient) may occur, especially in the case of injury to the bladder neck.
Anterior bladder wall and the bladder neck are extraperitoneal structures. A tear in these locations is almost always accompanied by pelvic fracture and causes extraperitoneal leakage of urine, leading to localized lower abdominal pain.
Dome of bladder
Spillage of blood, bowel contents, bile, pancreatic secretions, or urine into the peritoneal cavity can cause acute chemical peritonitis ❗, which is evidenced by diffuse abdominal pain and guarding. The superior and lateral surfaces of the bladder compose the dome of the bladder and are bordered by the peritoneal cavity. Therefore, rupture of the dome of the bladder causes urine to spill into the peritoneum, leading to peritonitis. Bladder rupture after blunt trauma is due to a sudden increase in intravesical pressure and most likely occurs following a blow to the lower abdomen when the bladder is full and distended.
In addition, irritation of the peritoneal lining of the right or left hemidiaphragm may cause referred pain to the ipsilateral shoulder (Kehr sign) as sensory innervation to the shoulder originates from the C3 to C5 spinal roots; these roots are also the origin of the phrenic nerve innervating the diaphragm.
Penetrating abdominal trauma (PAT)
Following completion of the primary survey, the evaluation of patients with PAT should focus on identifying potentially life-threatening indications for urgent exploratory laparotomy to prevent sepsis or exsanguinating hemorrhage.
The presence of any of the following suggests significant injury and is an indication for urgent exploratory laparotomy:
- Hemodynamic instability
- Peritonitis (rebound tenderness, guarding)
- Evisceration (ie, externally exposed intestines)
- Blood from a nasogastric tube or on rectal examination
Patients without indications for urgent laparotomy should undergo further evaluation, including local exploration of the wound and an extended ultrasound examination (eg, extended Focused Assessment with Sonography for Trauma [eFAST], which evaluates for pneumothorax and hemothorax in addition to intraperitoneal injuries).
Nausea (Antiemetics)
Ondansetron (Zofran): Serotonin (5HT) receptor antagonists (eg, ondansetron) that target the 5HT3 receptor are considered first-line treatment for chemotherapy-induced nausea. They have a low side-effect profile and are highly efficacious. These medications can be used to manage acute emesis but are also useful as prophylaxis, sometimes in combination with corticosteroids.
Metoclopromide (Regalin)
Promethazine (Phenergen) [Rectal]
Lorazepam (Ativan)
Scopolamine
Haldol
Bowel Regimen
Senna (stimulant laxative)
Miralax
Regalin
Feeding Tube
Dobhoff
Abdominal Pain: General
The first priority when evaluating abdominal pain is to determine whether the pain is acute or chronic. Sudden and/or severe onset of pain should lead the clinician toward an emergent evaluation.
Inflammatory Bowel Disease (Chron’s, Ulcerative Colitis)
Ulcerative colitis
Clinical features
- <4 watery bowel movements per day
- Hematochezia is rare or intermittent
Laboratory findings
- No anemia
- Elevated ESR & CRP (may be normal in mild disease)
Treatment
- 5-Aminosalicylic acid agents (eg, mesalamine, sulfasalazine)
Mild UC is defined as <4 watery bowel movements a day with intermittent hematochezia, normal inflammatory markers (eg, C-reactive protein, erythrocyte sedimentation rate), and no anemia. Dx: Colonoscopy is needed to confirm the diagnosis and usually shows inflammation and superficial ulcerations extending from the anorectum continuously to more proximal regions of the colon.
Both CD and UC present with chronic diarrhea, abdominal pain, anemia, and elevated inflammatory markers (eg, C-reactive protein, erythrocyte sedimentation rate).
Dx: Diagnosing IBD and distinguishing between CD and UC requires colonoscopy with biopsies. Based on the increased cancer risk, routine surveillance colonoscopy with biopsies every 1 to 2 years is warranted beginning 8 to 10 years after diagnosis.
Ulcerative colitis
- Inflammation is limited to the mucosa and submucosa
- Colonic mucosal inflammation and 👾crypt abscesses
- Rectum and Colon
- Continuous lesions
- Bloody diarrhea
Crohn disease
- Can affect the entire GI tract from mouth to anus
- Full thickness involvement of the gut wall, can lead to fistulas and deep abscesses.
- Noncaseating Granuloma formation on biopsies
- Cobblestoning, creeping fat
- Perianal disease with rectal sparing
Extraintestinal Manifestations:
Ankylosing spondylitis: Rare complication; seen more in CD than UC.
Aphthous stomatitis: Small ulcers between gums and lower lip or along tongue; related to disease activity.
Enteropathic arthritis (arthritic conditions associated with gastrointestinal disease)
Peripheral arthritis: Frequently classified as one of two types: type 1 affects large joints of arms and legs (elbows, wrists, knees, ankles); symptoms often acute and migratory; correlate with active bowel disease. Type 2 is symmetric, affects small joints, and is often chronic; unrelated to bowel disease activity.
Primary sclerosing cholangitis: Severe inflammation and scarring of bile ducts; more common in UC and men. Hx: Jaundice, nausea, pruritus, weight loss. May be complicated by cholangiocarcinoma or colon cancer.
Sacroiliitis: Pain and stiffness in lower spine and sacroiliac joints; may present before IBD symptoms.
Scleritis: Deep pain, redness of sclera. An ophthalmologic emergency.
Uveitis: Pain, blurry vision, photosensitivity, redness of eye. An ophthalmologic emergency (UC)
Osteoporosis: More common in women with CD. Periodic screening important.
Erythema nodosum: Tender, red nodules over 🦵shins and ankles; more common in UC and women; related to IBD disease activity.
Pyoderma gangrenosum: Papules and pustules coalesce to form deep, chronic ulcers, often on shins and ankles; more common in UC; related to IBD disease activity.
Tx:
5-Aminosalicylates
Sulfasalazine, olsalazine, balsalazide, mesalamine: oral, rectal
Initial management for mild UC is with 5-aminosalicylic acid (5-ASA) medications (eg, mesalamine, sulfasalazine, balsalazide), which are used for both induction and maintenance therapy. Mesalamine enemas or suppositories are preferred in patients with UC confined to the rectosigmoid, whereas oral 5-ASA medications are needed for more extensive disease.
Antibiotics (metronidazole, ciprofloxacin)
Glucocorticoids
Oral, intravenous, rectal
Budesonide
Immunomodulators
Methotrexate
Cyclosporine
6-MP, azathioprine
Biological Agents
Anti–TNF-α (adalimumab, certolizumab pegol, infliximab)
Natalizumab
Cx: Crohns
Strictures are a complication of Crohn disease that result from poorly controlled, severe inflammation. Smoking and young age (<30) at diagnosis are significant risk factors for uncontrolled inflammation and disease progression despite medical therapy.
SBO due to fibrotic stricture typically presents with bilious vomiting, severe abdominal pain, and either partial (ie, ability to pass gas but not stool) or complete (ie, inability to pass flatus or stool) obstruction. Abdominal examination commonly reveals distension and high-pitched (tympanic) bowel sounds.
Although medical treatment for Crohn disease (eg, infliximab) can reduce inflammation and may help prevent fibrotic stricture development it cannot resolve a stricture once one develops. Depending on the location and length of the stricture, surgical resection may be required.
[IBS] Irrirable Bowel SyndROME
Functional disorder of the gastrointestinal tract (with no identifiable organic cause). It is the most common gastrointestinal diagnosis in North America, with a prevalence of 10%-15%.
IBS is further subclassified as diarrhea-predominant, constipation-predominant, or mixed.
Hx: IBS presents most commonly in young women as chronic, crampy abdominal pain with alternating episodes of constipation and diarrhea. Passage of stool often relieves the pain.
Dx: Patients meeting the Rome III (IBS) diagnostic criteria have recurrent abdominal pain or discomfort at least 3 days each month in the past 3 months (12 weeks) (with onset more than 6 months earlier) [not necessarily consecutive] associated with two or more of the following:
- Improvement with defecation;
- Onset associated with change in frequency of stool;
- Onset associated with change in form (appearance) of stool.
Dx: Further testing is not required unless alarm features are present that suggest an alternate diagnosis.
Normal colonoscopy
Alarm symptoms (not present) include onset after age 50 years, brief history of symptoms, weight loss, nocturnal symptoms, family history of colon cancer, rectal bleeding, and recent antibiotic use.
- Older age of onset (≥50)
- Gastrointestinal bleeding
- Nocturnal diarrhea
- Worsening pain
- Unintended weight loss
- Iron deficiency anemia
- Elevated C-reactive protein
- Positive fecal lactoferrin or calprotectin
- Family history of early colon cancer or IBD
Tx: FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols)diet
Celiac disease
In children:
Risk factors
- First-degree relative with celiac disease
- Autoimmune disorders
- Down syndrome
Clinical features
- Abdominal pain, bloating, diarrhea
- Failure to thrive, short stature
- Dermatitis herpetiformis, a pruritic papular or vesicular rash 🌹 associated with celiac disease, is located on the knees, elbows, forearms, and buttocks.
Workup
- ↑ Tissue transglutaminase IgA antibody
- Intestinal biopsy (villous atrophy)
Treatment
- Gluten-free diet
Celiac disease occurs in genetically predisposed persons with haplotype HLA-DQ2 or HLA-DQ8
Hx: Abdominal pain, bloating, diarrhea triggered by ingestion of gluten that is present in wheat, rye, and barley. Malabsorption (weight loss, postprandial bloating, and bulky, foul-smelling stools that float), malnutruition, and iron deficiency anemia may be present.
- Fat and protein: loss of muscle mass, loss of subcutaenous fat, fatigue
- Iron: Pallor, fatigue
- Calcium and Vitamin D: Bone pain (osteomalacia), fracture (osteoporosis)
- Vitamin K: Easy brusing
- Vitamin A: Hyperkeratosis
Dx:
IgA anti-tissue transglutaminase and IgA anti-endomysial antibodies.
❗ Many patients with biopsy-confirmed celiac disease will have negative results on IgA antibody testing due to an associated selective IgA deficiency, which is common in celiac disease. If IgA serology is negative but the suspicion for celiac disease is high, total IgA should be measured (or IgG-based serologic testing should be done).
🌈 D-xylose is a monosaccharide that can be absorbed in the proximal small intestine without degradation by pancreatic or brush border enzymes. It is subsequently excreted in the urine. In the D-xylose test, the patient is given an oral dose of D-xylose, with subsequent assay of urine and venous blood. Patients with proximal small intestinal mucosal disease (eg, celiac disease) cannot absorb the D-xylose in the intestine, and urinary and venous D-xylose levels will be low. By contrast, patients with malabsorption due to enzyme deficiencies (eg, chronic pancreatitis) will have normal absorption of D-xylose
Tx: Avoidance of gluten-containing foods is curative
🚧 SBO
High-pitched bowel sounds on examination. In association with the abdominal x-rays demonstrating distended loops of bowel with air-fluid levels.
Hx: Nausea, vomiting, and distension; colicky pain
Dx: Obstructive pattern seen on CT or abdominal series
Px: Hyperactive bowel sounds
SBO is further categorized by anatomic location (ie, proximal versus mid/distal) or simple versus strangulated.
Complete proximal obstructions are characterized by early vomiting, abdominal discomfort, and abnormal contrast filling on x-ray.
Mid or distal obstructions typically present as colicky abdominal pain, delayed vomiting, prominent abdominal distension, constipation-obstipation, hyperactive bowel sounds, and dilated loops of bowel on abdominal x-ray.
Simple obstruction refers to luminal occlusion; strangulation refers to loss of blood supply to the bowel wall. Patients with strangulated obstructions may have peritoneal signs (eg, rigidity, rebound) and signs of shock; fever, tachycardia, and leukocytosis are late findings.
Adhesions are by far the most common cause of SBO. They may be congenital in children (eg, Ladd’s bands), but typically result from abdominal operations or inflammatory processes. This adult patient with an SBO is likely to have had abdominal surgery, such as an appendectomy.
Paralytic (adynamic) ileus
Ileus is most commonly a complication of abdominal surgery but can also be seen in other conditions such as retroperitoneal/abdominal hemorrhage, intraabdominal inflammation (eg, pancreatitis), intestinal ischemia, and electrolyte abnormalities. Contributors to the pathophysiology of ileus include irritation and temporary paralysis of the abdominal sympathetic and parasympathetic nervous system, local release of inflammatory mediators, and opioid analgesic use.
Signs and symptoms of ileus include nausea, vomiting, abdominal distension, failure to pass flatus or stool (obstipation), and hypoactive or absent bowel sounds. The diagnosis is clinical, but abdominal x-rays (classically revealing uniformly dilated, gas-filled loops of bowel with no transition point) can be helpful in confirmation.
Management is conservative and includes bowel rest, supportive care, and treatment of secondary causes.
Postoperative ileus
Delayed return of bowel function >72 hours after surgery. Risk factors include surgical complications (eg, ureteral injury), bowel manipulation (eg, laparotomy), and longer surgery duration due to increased intraabdominal inflammation and elevated sympathetic nervous system tone. Patients with postoperative ileus have temporary bowel paralysis (ie, no forward peristalsis), causing backup of gastric secretions and gas that results in abdominal distension and vomiting (eg, hypokalemia, dehydration [elevated creatinine]). Other signs include decreased bowel sounds and absent flatus.
Diagnosis is primarily clinical, although imaging can help differentiate ileus from small bowel obstruction (SBO). Abdominal x-rays in patients with ileus typically reveal uniformly dilated bowel loops due to generalized bowel paralysis throughout both small and large bowel.
In contrast, patients with SBO have a discrete transition point (ie, the obstruction) that results in dilated small bowel proximal to the obstruction and decompressed large bowel (ie, absent rectal gas) distally.
Postoperative ileus typically self-resolves as bowel motility gradually returns; therefore, patients are conservatively managed with antiemetics, bowel rest, and serial examinations. Opiates, which further decrease bowel motility, should be avoided if possible.
Gallstone ileus
Occurs when a gallstone passes through a biliary-enteric fistula into the small bowel. As the stone advances it may cause intermittent “tumbling” obstruction with diffuse abdominal pain and vomiting until finally lodging in the ileum, the narrowest section of the bowels, several days later.
In addition to experiencing colicky pain and vomiting, patients may report distension and inability to pass flatus or stool and show signs of hypovolemia (eg, hypotension, tachycardia). Stones can occasionally also lodge in the stomach, jejunum, or colon. Cholecystitis, which predisposes to biliary-enteric adhesions, is the most important risk factor, and patients are more commonly elderly women, which reflects their higher prevalence of gallstone disease.
Diagnosis can be confirmed by abdominal CT scan, which may reveal gallbladder wall thickening, pneumobilia, and an obstructing stone. Treatment is surgical and involves removal of the stone and either simultaneous or delayed cholecystectomy.
Groin hernias
Groin hernias (ie, inguinal, femoral) result from protrusion of intraabdominal (eg, small bowel) or pelvic contents through the abdominal wall.
Uncomplicated hernias typically present as a groin bulge that becomes more prominent with increased intraabdominal pressure (eg, cough, Valsalva).
Femoral Hernia - A displacement of abdominal or pelvic contents through a widened or laxed femoral ring (medial to the femoral artery and lateral to the inguinal ligament).
Risk factors include chronic cough (eg, chronic obstructive pulmonary disease), constipation, and smoking. Most cases arise in older women and present as a nonpulsatile mass in the groin. The mass generally worsens with increased abdominal pressure (eg, standing, Valsalva maneuver, coughing) and improves with decreased abdominal pressure (eg, lying down). When a bowel loop is present within the hernia, it is often tympanitic to percussion.
Because femoral hernias pass through a narrow orifice, they are associated with a substantial risk of incarceration (trapping of abdominal/pelvic contents within the hernia) and strangulation (constriction of blood flow with subsequent ischemia/necrosis).
Therefore, asymptomatic femoral hernias are generally referred for elective surgical repair to prevent potentially life-threatening complications and subsequent high-risk emergency surgery, which is associated with an increased risk of morbidity (eg, bowel resection) and mortality.
Inguinal hernias (hernia above the inguinal ligament) are associated with a lower risk for incarceration and strangulation because hernia contents pass through a wider orifice. Therefore, most asymptomatic inguinal hernias can be managed with reassurance and watchful waiting. Observation can also be considered for patients with chronic (>3 months), stable femoral hernias, but is not recommended for most patients with femoral hernias due to the risk of incarceration.
Cx: Incarceration occurs when hernia contents become trapped within the hernia sac, which can result in SBO; reduced venous outflow eventually leads to ischemia and necrosis (strangulation).
Differential Diagnosis: Midepigastric or Periumbilical:
Acute pancreatitis
Inferior myocardial infarction
Perforating peptic ulcer
Mesenteric ischemia
Small bowel obstruction
Aortic dissection or rupture
Diabetic ketoacidosis
Celiac disease
Others (LUQ): PUD, perforated ulcer, gastritis, splenic
injury, abscess, reflux, dissecting aortic
aneurysm, thoracic causes, pyelonephritis,
nephrolithiasis, hiatal hernia (strangulated
paraesophageal hernia), Boerhaave’s
syndrome, Mallory-Weiss tear, splenic
artery aneurysm, colon disease
AAA
Most AAAs are discovered incidentally or on screening examination.
Patients may present with symptoms related to aneurysm expansion or leakage, including back or abdominal pain. Occasionally, patients may have symptoms related to aneurysm-related thrombosis, especially in the lower extremities. Patients with a ruptured AAA are often hypotensive, and a pulsatile mass may be palpated in some patients. The lack of a pulsatile mass, however, is not reliable in excluding the diagnosis, especially in obese patients.
AAAs can be adequately evaluated either by ultrasound or by CT angiography. CT angiography is generally indicated for hemodynamically stable patients with suspected rupture, as the CT can provide additional information about aortic anatomy that will assist in intervention.
All patients with AAAs should have aggressive treatment of hypertension, hyperlipidemia, and especially tobacco dependence, as associated cardiovascular disease is very common in patients with AAAs.
Surgical treatment of asymptomatic patients who have a life expectancy of >2 years is performed when the AAA has reached a diameter of 5.5 cm or is expanding at a rate of >0.5 cm in 6 months.
Acute pancreatitis
Occurs when the pancreatic enzyme trypsinogen is prematurely activated to trypsin, which in turn activates pancreatic zymogens. The resulting pancreatic autodigestion leads to an inflammatory response that causes further pancreatic damage.
Most cases of acute pancreatitis are mild (interstitial) and self-limited, but in severe cases, the inflammation may progress to a systemic inflammatory response that can lead to capillary leak syndrome, multiple organ failure, and death. Repeated episodes of acute pancreatitis may result in chronic pancreatitis and pancreatic endocrine and exocrine insufficiency.
The most common etiologies of acute pancreatitis in the United States are: Gallstones or Alcohol. Gallstones cause the majority of cases of pancreatitis. Alcohol causes about 30% of the cases. Ten to thirty percent are idiopathic. Pancreatitis also may be caused by very high serum ⚪ triglyceride levels (>500 mg/dL)[third most common], 🥛 hypercalcemia, sphincter of Oddi dysfunction, trauma, surgery, cystic fibrosis and other genetic disorders, or penetrating peptic ulcer or as a complication of endoscopic retrograde cholangiopancreatography (ERCP).
Hx: The most common symptom of acute pancreatitis is the sudden onset of severe epigastric or diffuse abdominal pain radiating to the back. The pain usually may improve when the patient sits up or leans forward.
Drug-induced pancreatitis accounts for 5% of cases:
- Diuretics (furosemide, thiazides)
- Drugs for inflammatory bowel disease (sulfasalazine, 5-ASA)
- Immunosuppressive agents (azathioprine)
- HIV-related medications (didanosine, pentamidine)
- Antibiotics (metronidazole, tetracycline)
- Valproic acid
Nausea, vomiting, and fever are common.
Px: Abdominal tenderness (diffuse or epigastric), guarding, and distension are common in acute uncomplicated pancreatitis. Diminished bowel sounds may point to an associated ileus. Several physical findings may suggest a specific etiology; for example, jaundice suggests biliary obstruction, and eruptive xanthomas suggest hypertriglyceridemia. Evaluate for hypovolemia (tachycardia, hypotension), infection, or gastrointestinal (GI) bleeding. Large pseudocysts may be palpable and painful. The Grey-Turner or Cullen sign (painless ecchymoses in the flank or periumbilical region, respectively) suggests retroperitoneal bleeding.
Dx: Diagnosis of acute pancreatitis requires at least two of the triad of clinical symptoms, elevated serum amylase or lipase, and typical findings on imaging.
Serum lipase is more sensitive and specific than amylase and stays elevated up to 14 days after an episode of acute pancreatitis. Measuring serum lipase alone is sufficient to confirm the diagnosis of acute pancreatitis in the appropriate clinical setting. However, other conditions may also cause elevation of serum lipase, such as: Intestinal ischemia or obstruction, Duodenal ulcer, Ketoacidosis, Celiac disease, Macrolipasemia, Head trauma, intracranial mass, Kidney failure, and Heparin.
Imaging of the pancreas in acute pancreatitis is NOT indicated in all patients but should be considered in those with moderate or severe pancreatitis or persistent fever and in those who do not improve clinically within 48 to 72 hours to confirm the diagnosis, exclude other intraabdominal processes, grade the severity of pancreatitis, and diagnose local complications (pancreatic necrosis, pseudocyst, abscess).
A right upper-quadrant ultrasound 🔊 is advised for all patients with suspected gallstone pancreatitis as it provides the most accurate information regarding the presence of gallstones. If the ultrasound is nondiagnostic and there is high clinical suspicion for common bile duct disease, endoscopic retrograde cholangiopancreatography (ERCP) may be performed to better visualize the biliary tree.
CT may show enlargement or irregular contour of the gland, peripancreatic inflammation, and fluid collections. Pancreatic necrosis is identified by areas of nonenhancement on a contrast CT; Prominent peripancreatic fluid and fat-stranding
ERCP is indicated only if there is evidence of biliary obstruction (jaundice, common bile duct dilatation, or elevated liver enzymes) in a patient with cholangitis (right upper quadrant pain, fever, jaundice) or in a patient with biliary pancreatitis who is not improving clinically and whose liver enzymes are rising. Stone extraction with biliary sphincterotomy improves mortality, decreases the risk of cholangitis and biliary sepsis, and may prevent further attacks of acute biliary pancreatitis. Surgical debridement or percutaneous drainage is indicated for infected pancreatic necrosis. Cholecystectomy is indicated in patients with biliary pancreatitis to prevent recurrence.
Third spacing of fluid and hemoconcentration, identified by increased BUN, increased creatinine, and sometimes increased hematocrit, may predict morbidity and mortality because they reflect severity of capillary leak. Organ failure is defined by the presence of shock (systolic blood pressure <90 mm Hg), respiratory insufficiency (arterial PO2 <55 mm Hg), acute kidney injury (serum creatinine >2 mg/dL), or GI bleeding (>500 mL/24 h). Most patients with multiple organ system involvement have pancreatic necrosis involving 30% to 50% of the pancreas, often with infection; these patients have a very high mortality rate.
Tx: Mild acute pancreatitis is usually self-limited and is treated with bowel rest, intravenous hydration, antiemetics, and opioid analgesics.
NPO: Oral intake is withheld until there is clear clinical improvement
Nasojejunal enteral feeding in patients who are NOT improving within 72 to 96 hours.
Nasogastric suction only in patients with refractory vomiting caused by ileus.
Cx: Pancreatitis may cause significant systemic complications, mediated primarily by the effect of tissue damage and the release of cytokines and inflammatory mediators. These include hypocalcemia, hyperglycemia, acute kidney injury, disseminated intravascular coagulation, and acute respiratory distress syndrome.
Pancreatic pseudocysts are the most common complication of acute pancreatitis and may present several weeks after an episode of acute pancreatitis. A pseudocyst is a collection of pancreatic fluid with a fibrous, nonepithelialized lining. Tx: Pseudocysts are usually asymptomatic and usually resolve spontaneously. Suspect a persistent pseudocyst if pain, anorexia, or weight loss persists for several weeks. Symptomatic pseudocysts require drainage (percutaneous, endoscopic, or surgical). Pancreatic abscess (infected pseudocyst) presents with worsening abdominal pain, fever, and leukocytosis. Treatment includes antibiotics and drainage.
The best predictors of higher morbidity and mortality in patients with acute pancreatitis are those associated with hemoconcentration because it serves as a marker of capillary leak. Patients with severe disease tend to have elevated levels of blood urea nitrogen, serum creatinine, and occasionally hematocrit (all markers of hemoconcentration). Of these factors, the blood urea nitrogen level appears to be the most accurate for predicting severity. Other factors that predispose patients to a poor prognosis are multiple medical comorbidities, age greater than 70 years, and body mass index greater than 30.
Ranson’s criteria assess the severity and prognosis of pancreatitis. On admission, five criteria are considered.
It is a poor prognostic sign if:
Age > 55
WBC is greater than 16,000/mm3
Glucose is greater than 200 mg/dL
LDH is greater than 350 IU/L
AST is greater than 250 U/L
Six other criteria reflect the development of complications and include:
A decrease in hematocrit greater than 10 mg/dL
BUN increase greater than 5 mg/dL
Calcium less than 8 mg/dL
PaO2 less than 60 mm Hg
Base deficit greater than 4 mEq/L
Fluid sequestration greater than 6 L
These are assessed during the
first 48 hours of admission.
Perforated viscus: Very sudden onset (in AP, pain gradually increases over 30 min to 1 h). Intraperitoneal air present on radiographs.
Autoimmune Pancreatitis: Dx: IgG4
Chronic pancreatitis
Chronic pancreatitis is caused by pancreatic damage from repeated attacks of acute pancreatitis.
- At least 80% of patients with chronic pancreatitis have chronic abdominal pain, characteristically constant midepigastric pain radiating to the back and exacerbated by food.
- Destruction of exocrine pancreatic tissue may result in malabsorption, leading to steatorrhea and weight loss.
- Destruction of insulin-producing β-cells may lead to 🍭diabetes mellitus; concurrent destruction of glucagon-producing α-cells increases the risk of hypoglycemia in patients with diabetes.
In chronic pancreatitis, pancreatic calcifications can be seen on abdominal radiographs and CT scans, which may also show parenchymal atrophy or ductal dilatation in the pancreas
As the disease progresses, destruction of pancreatic islet and acinar cells leads to endocrine (ie, diabetes) and exocrine insufficiency, resulting in protein and fat malabsorption, steatorrhea, weight loss, and fat-soluble vitamin deficiencies. Fecal elastase is a noninvasive test with high sensitivity and specificity for severe pancreatic exocrine insufficiency. Elastase is a proenzyme (zymogen) produced in pancreatic acinar cells and activated by trypsin in the duodenal lumen; low levels indicate severe exocrine insufficiency. An alternate noninvasive test is serum trypsinogen, which would also be low in this setting. Treatment involves pancreatic enzyme replacement, which includes lipase to aid in fat digestion and improve steatorrhea.
Pancreatic Cancer
Risk factors
- Smoking
- Hereditary pancreatitis
- Nonhereditary chronic pancreatitis
- Obesity & lack of physical activity
Clinical presentation
- Systemic symptoms (eg, weight loss, anorexia) (>85%)
- Abdominal pain/back pain (80%)
- Jaundice (56%)
- Recent-onset atypical diabetes mellitus
- Unexplained migratory superficial thrombophlebitis
- Hepatomegaly & ascites with metastasis
Laboratory studies
- Cholestasis (↑ alkaline phosphatase & direct bilirubin)
- ↑ Cancer-associated antigen 19-9 (not as a screening test)
- Abdominal ultrasound (if jaundiced) or CT scan (if no jaundice)[body and tail tumors]
Pancreatic carcinoma causes painless obstructive jaundice with elevated alkaline phosphatase and normal transaminases.
🥃 Courvoisier’s sign - Painless jaundice and abdominal fullness
Approximately 25% of patients with pancreatic cancer are diagnosed with DM <2 years prior to discovery of the tumor. In particular, atypical DM (eg, DM presenting in a thin, older patient) should raise suspicion for pancreatic cancer, particularly when accompanied by other suggestive findings (eg, pain, weight loss). It is unclear whether DM promotes carcinogenesis or whether DM occurs as a consequence of a paraneoplastic syndrome from adrenomedullin secretion, leading to pancreatic beta cell dysfunction.
Screening for pancreatic cancer is not recommended in adults with new-onset diabetes because the incidence of DM is much greater than pancreatic cancer. However, those who have symptoms of pancreatic cancer such as gnawing, constant epigastric pain and weight loss require further evaluation with CT scan of the abdomen.
✖ Abdominal ultrasound is used in the initial evaluation of patients with painless jaundice, anorexia, or weight loss. However, it is not the preferred modality for screening patients who have abdominal pain without jaundice; it often misses smaller (potentially resectable) tumors; and it does not delineate tumor extension as well as CT does.
Cx: Migratory superficial thrombophlebitis, classically known as (Trousseau’s syndrome). Trousseau’s syndrome is a hypercoagulable disorder that usually presents with unexplained superficial venous thrombosis at unusual sites (eg, arm, chest area). The syndrome is usually diagnosed prior to (sometimes months to years before) or at the same time as an occult visceral malignancy.
Trousseau’s syndrome is usually associated with cancer involving the pancreas (most common), lung, prostate, stomach, and colon, and acute leukemias. Factors associated with higher risk of pancreatic cancer include increasing age and smoking. The tumor likely releases mucins that react with platelets to form platelet-rich microthrombi.
VIPoma
A rare tumor affecting the pancreatic cells that produce vasoactive intestinal peptide (VIP). Most affected adults are between ages 30-50. VIP binds to intestinal epithelial cells to increase fluid and electrolyte secretion in the intestinal lumen. Most patients develop VIPoma syndrome (pancreatic cholera) with watery diarrhea (can be tea colored and odorless), muscle weakness/cramps (due to hypokalemia), and hypo- or achlorhydria (due to decreased gastric acid secretion). The stool volume can be greater than 3L/day, leading to significant volume depletion. Other findings include facial flushing, lethargy, nausea, vomiting, abdominal pain, and weight loss. Patients can also have coexisting hyperparathyroidism as part of multiple endocrine neoplasia (MEN) syndrome.
Laboratory studies usually show hypokalemia due to increased intestinal potassium secretion. Other possible findings include hypercalcemia (due to increased bone resorption) and hyperglycemia (due to increased glycogenolysis). Stool studies are consistent with secretory diarrhea and show increased stool sodium and stool osmolal gap <50 mOsm/kg. A VIP level >75 pg/mL confirms VIPoma diagnosis. Abdominal imaging (cross-sectional triple-phase abdominal CT or MRI) can localize the tumor in the pancreas. Nearly 75% of VIPomas are in the pancreatic tail and 60%-80% have metastasized to the liver by the time of diagnosis. Treatment involves intravenous volume repletion, octreotide to decrease diarrhea, and possible hepatic resection in patients with metastasis to the liver.
Glucagonoma
Glucagonoma
Clinical presentation
- Weight loss
- Necrolytic migratory erythema: erythematous papules that coalesce to form large, indurated plaques with central clearing
- 🍭 Diabetes mellitus/hyperglycemia
- Gastrointestinal symptoms (eg, diarrhea, anorexia, abdominal pain)
Diagnosis
- Markedly elevated glucagon level
- Abdominal imaging (MRI or CT scan)
A pancreatic neuroendocrine tumor characterized by the unregulated release of glucagon. Manifestations reflect the effects of glucagon, which increases amino acid oxidation and has catabolic actions.
Glucagonoma is often diagnosed late in the disease course due to nonspecific early features; necrolytic migratory erythema (NME) is the presenting feature in ~70% of patients. NME, likely due to amino acid deficiency, is characterized by painful/pruritic papules that coalesce to form large, indurated plaques with scaling and central clearing on the face, groin, and extremities. The excess glucagon also causes hyperglycemia/diabetes mellitus, although this is usually mild and rarely requires insulin.
Other common features include weight loss (catabolic action of glucagon), diarrhea (secretion of glucagon and other molecules [eg, secretin]), venous thromboembolism, and neuropsychiatric symptoms (eg, depression, psychosis).
Laboratory evaluation typically shows normocytic, normochromic anemia, which may be due to anemia of chronic disease or a direct effect of glucagon on erythropoiesis. A markedly elevated serum glucagon level (>500 pg/mL) confirms the diagnosis. Although glucagon is increased in other conditions (eg, hypoglycemia, Cushing syndrome, pancreatitis), the elevations are typically mild to moderate. Abdominal imaging (CT scan or MRI) can localize the tumor and evaluate for metastases.
Diabetic ketoacidosis
Blood glucose always elevated; anion gap always present
Dysphagia
Dysphagia (difficulty swallowing) is categorized as either oropharyngeal (difficulty initiating a swallow, with coughing/choking after eating) or esophageal (sensation of food stuck in the esophagus). Esophageal dysphagia to both solids and liquids indicates a motility disorder, with intermittent (eg, esophageal spasm) or progressive (eg, achalasia) symptoms depending on the underlying condition. Esophageal dysphagia to solids generally reflects mechanical obstruction; symptoms can also be progressive (eg, from solids to liquids), which suggests a developing stricture or cancer, or intermittent.